The U.S. government will no longer penalize American companies for making six popular peptides

It won’t take action against compounding pharmacies that make popular wellness products like BPC-157 and TB-500.

Source:MarketWatch
友情提醒:請廣大讀者理性看待市場資訊,切實提高風險意識。站內所有內容僅系市場資訊或相關方觀點,不構成任何形式投資建議。